🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Prostate Cancer Stage I

Combination Study of Antibiotics With Enzalutamide (PROMIZE) NCT06126731Phase 1, Phase 22 sites📍 Bellinzona📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Enzalutamide 40mg, Amoxicillin 500mg, Metronidazole 400mg, Vancomycin 125mg, Ciprofloxacin 500g Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer NCT02971358NA1 site📍 Vienna Medical University of Vienna · Tests: Radical prostatectomy COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226Phase 1, Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metf… Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer NCT05646550Phase 11 site📍 Tübingen University Hospital Tuebingen · Tests: CC-1 Infusion A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors NCT06926283Phase 14 sites📍 Changsha📍 Hangzhou📍 Beijing Hangzhou DAC Biotechnology Co., Ltd. · Tests: DXC008 High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy NCT06982469n/a1 site📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: Brachytherapy TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites📍 Tucson📍 Tucson📍 Tucson Pfizer · Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients NCT06615752Phase 1, Phase 21 site📍 Los Angeles Charles Drew University of Medicine and Science · Tests: green tea and quercetin + docetaxel, Placebo + docetaxel A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer NCT07735377Phase 11 site📍 Guangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-6914 Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA NCT06600698Phase 1, Phase 21 site📍 Hershey Milton S. Hershey Medical Center · Tests: INM176 Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites📍 Atlanta📍 Nashville📍 San Antonio Novartis Pharmaceuticals · Tests: GVV858, Fulvestrant, Letrozole A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors NCT05740956Phase 11 site📍 Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10502 Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: SX-682, DTX Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer NCT03789253n/a1 site📍 Taipei National Taiwan University Hospital A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours NCT07533708Phase 15 sites📍 Nanchang📍 Naning📍 Nanjing Shanghai Henlius Biotech · Tests: HLX3902 Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance NCT06733350Phase 41 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging, Patient Observation, Questionnaire Administrati… IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer NCT03880422NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Dietary Intervention, Educational Intervention, Exercise Intervention, Quality-of-Life Assessment, Survey Administration A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC NCT07255664Phase 1, Phase 21 site📍 Frankfurt CuraCell TX AB · Tests: CC-38, Pembrolizumab, Cyclophosphamid, Interleukin-2, Uromitexan Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy NCT06940271NA1 site📍 Jacksonville Mayo Clinic · Tests: Allografting, Survey Administration Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer NCT06178354NA1 site📍 Sacramento University of California, Davis · Tests: Cryosurgery, High-Intensity Focused Ultrasound Ablation, Survey Administration Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer NCT07468903NA1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biopsy Procedure, Biospecimen Collection, High-Dose Rate Brachytherapy, Multiparametric Magnetic Resonance Imaging, PSM… Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer NCT05113537Phase 1, Phase 21 site📍 San Francisco Vadim S Koshkin · Tests: Abemaciclib, Lutetium Lu 177-PSMA-617 Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies NCT05417594Phase 1, Phase 232 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: AZD9574, Temozolomide (TMZ), [11C]AZ1419 3391, Trastuzumab Deruxtecan (T-DXd), Datopotamab Deruxtecan (Dato-DXd) rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance NCT05852041EARLY Phase 11 site📍 Chicago Northwestern University · Tests: Biopsy of Prostate, Decipher Prostate Cancer Test, Flotufolastat F-18 Gallium, Magnetic Resonance Imaging, Multiparamet… CART-PSMA Cells for Advanced Prostate Cancer NCT05656573Phase 11 site📍 Beijing Nova Therapeutics LLC · Tests: CART-PSMA cells Phase I Human Analytics (HALO) Study NCT05423860n/a1 site📍 Indian Wells HALO Diagnostics · Tests: no interventions will be performed (observational) Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma NCT07316686Phase 11 site📍 São Paulo Instituto do Cancer do Estado de São Paulo · Tests: Docetaxel 50mg/m2, Docetaxel 60mg/m2, Docetaxel 75 mg/m², 177Lu-PSMA-I&T
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy